[1]张新玲,廖凯兵.颈动脉支架成形术的远期疗效及支架内再狭窄的相关回归分析[J].卒中与神经疾病杂志,2024,31(06):526-530.[doi:10.3969/j.issn.1007-0478.2024.06.003]
点击复制

颈动脉支架成形术的远期疗效及支架内再狭窄的相关回归分析()
分享到：

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第31卷
期数:
2024年06期
页码:
526-530
栏目:
血管内治疗
出版日期:
2024-12-20

文章信息/Info

文章编号:
1007-0478(2024)06-0526-05
作者:
张新玲; 廖凯兵
430000 武汉,湖北中医药大学检验学院(张新玲); 湖北省中西医结合医院放射科[廖凯兵(通信作者)]
关键词:
颈动脉支架成形术 颈动脉狭窄 长期随访 支架内再狭窄 脑卒中
分类号:
R543.5
DOI:
10.3969/j.issn.1007-0478.2024.06.003
文献标志码:
A
摘要:
目的 探讨颈段颈动脉支架成形术后长期预后及支架内再狭窄的相关危险因素。方法 回顾性收集湖北省中西医结合医院2013年1月-2023年6月采用自膨式支架进行血管成形术治疗颈段颈动脉狭窄患者的临床和影像学相关资料,分析临床资料及随访表现。结果 共纳入200例患者,其中男147例(73.5%),女53例(26.5%),平均年龄(66.26±8.06)岁,植入支架200枚,手术成功率为100%; 随访期间病死率为0.5%,脑卒中的发生率为8%,术后再狭窄的发生率为9.5%; 单因素回归分析显示,高脂血症、术后残余狭窄与术后支架内再狭窄有关; logistic回归分析显示,高脂血症和术后残余狭窄是术后支架内再狭窄的独立危险因素; 高脂血症、术后残余狭窄对术后支架内再狭窄预测的曲线下面积(Area under curve,AUC)分别为0.651、0.832; 高脂血症对于再狭窄有一定的诊断价值(P<0.05,95%CI=0.509～0.793); 术后残余狭窄对于再狭窄诊断价值较高(P<0.05,95%CI=0.704～0.959)。结论 颈动脉支架成形术远期疗效较好,对于预防脑卒中具有长期安全性和有效性,高脂血症和术后残余狭窄是术后支架内再狭窄的独立危险因素。

参考文献/References:

[1] Kamel H,Navi BB,Merkler AE,et al.Reclassification of ischemic stroke etiological subtypes on the basis of high-risk nonstenosing carotid plaque[J].Stroke,2020,51(2):504-510.
[2] Feigin VL,Stark BA,Johnson CO,et al.Global, regional, and national burden of stroke and its risk factors, 1990-2019:a systematic analysis for the global burden of disease study 2019[J].The Lancet Neurology,2021,20(10):795-820.
[3] Tuw J,Yan F,Chao BH,et al.Treatment and 1-year prognosis of ischemic stroke in China in 2018:a hospital-based study from bigdata observatory platform for stroke of China[J].Stroke,2022,53(9): e415-e7.
[4] Zhu Z,Yu WG.Update in the treatment of extracranial atherosclerotic disease for stroke prevention[J].Stroke Vasc Neurol,2020,5(1):65-70.
[5] Bonati LH,Dobson J,Featherstone RL,et al.Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis:the international carotid stenting study(ICSS)randomised trial[J].Lancet,2015,385(9967):529-538.
[6] Halliday A,Bulbulia R,Bonati LH,et al.Second asymptomatic carotid surgery trial(ACST-2):a randomised comparison of carotid artery stenting versus carotid endarterectomy[J].Lancet,2021,398(10305):1065-1073.
[7] Jonsson M,Lindström D,Gillgren P,et al.Long-term outcome after carotid artery stenting:a population-based matched cohort study[J].Stroke,2016,47(8):2083-2089.
[8] Leko N,Maretta M,korvánek M,et al.Predictors of outcome events and 6-year mortality after carotid endarterectomy and carotid stenting in patients with carotid artery stenosis[J].Neurol Neurochir Pol,2021,55(1):67-73.
[9] Brott TG,Hobson RW2,Howard G,et al.Stenting versus endarterectomy for treatment of carotid-artery stenosis[J].N Engl J Med,2010,363(1):11-23.
[10] Brott TG,Howard G,Roubin GS,et al.Long-term results of stenting versus endarterectomy for carotid-artery stenosis[J].N Engl J Med,2016,374(11):1021-1031.
[11] Armstrong EJ,Kokkinidis DG.Restenosis after carotid artery stenting[J].Cardiovasc Revasc Med,2021,24:70-71.
[12] Dai ZZ,Xu GL.Restenosis after carotid artery stenting[J].Vascular,2017,25(6):576-586.
[13] Stilo F,Montelione N,Calandrelli R,et al.The management of carotid restenosis: a comprehensive review[J].Ann Transl Med,2020,8(19):1272.
[14] Arquizan C,Trinquart L,Touboul PJ,et al.Restenosis is more frequent after carotid stenting than after endarterectomy: the EVA-3S study[J].Stroke,2011,42(4):1015-1020.
[15] Hunter GC.Edgar J. Poth memorial/W.L. gore and associates, Inc. lectureship. the clinical and pathological spectrum of recurrent carotid stenosis[J].Am J Surg,1997,174(6):583-588.
[16] Trisal V,Paulson T,Hans SS,et al.Carotid artery restenosis: an ongoing disease process[J].Am Surg,2002,68(3):275-279; discussion 279-80.
[17] Ebert MLA,Schmidt VF,Pfaff L,et al.Animal models of neointimal hyperplasia and restenosis: Species-Specific differences and implications for translational research[J].JACC-Basic To Translational Science,2021,6(11):900-917.
[18] Bergheanu SC,Bodde MC,Jukema JW.Pathophysiology and treatment of atherosclerosis:current view and future perspective on lipoprotein modification treatment[J].Neth Heart J,2017,25(4):231-242.
[19] Lal BK,Beach KW,Roubin GS,et al.Restenosis after carotid artery stenting and endarterectomy:a secondary analysis of CREST, a randomised controlled trial[J].Lancet Neurol,2012,11(9):755-763.
[20] Servadei F,Anemona L,Cardellini M,et al.The risk of carotid plaque instability in patients with metabolic syndrome is higher in women with hypertriglyceridemia[J].Cardiovasc Diabetol,2021,20(1):98.
[21] Miura Y,Kanamaru H,Yasuda R,et al.Nonfasting triglyceride as an Independent predictor of carotid restenosis after carotid endarterectomy or carotid artery stenting[J].World Neurosurg,2021,156:e415-e425.
[22] Cosottini M,Michelassi MC,Bencivelli W,et al.In stent restenosis predictors after carotid artery stenting[J].Stroke Res Treat,2010,2010:864724.
[23] Lai PMR,Baig AA,Khawar WI,et al.Residual in-stent carotid stenosis and cigarette smoking are independent predictors of carotid restenosis after carotid artery stenting-results from 738 carotid artery stenting procedures at a single center[J].Neurosurgery,2022: 10.1227.
[24] 潘文龙,赵浩,王备备.颈动脉支架植入术患者的围术期护理[J].介入放射学杂志,2019,28(7):687-690.
[25] 王春梅,隗立兵,宋礼坡,等.颈动脉支架植入术后管理[J].介入放射学杂志,2021,30(1):92-96.
[26] 卢浩浩,郑传胜,梁惠民,等.59例颈动脉支架置入术的临床分析[J].临床放射学杂志,2016,35(3):458-461.

更新日期/Last Update: 2024-12-20